This is the official guideline endorsed by the specialty associations involved in the care of
head and neck cancer patients in the UK. There has been significant debate in the
management of oropharyngeal cancer in the last decade, especially in light of the increased
incidence, clarity on the role of the human papilloma virus in this disease and the treatment
responsiveness of the human papilloma virus positive cancers. This paper discusses the
evidence base pertaining to the management of oropharyngeal cancer and provides …

This is the official guideline endorsed by the specialty associations involved in the care of
head and neck cancer patients in the UK. With an age standardised incidence rate of 0.63
per 100 000 population, hypopharynx cancers account for a small proportion of the head
and neck cancer workload in the UK, and thus suffer from the lack of high level evidence.
This paper discusses the evidence base pertaining to the management of hypopharyngeal
cancer and provides recommendations on management for this group of patients receiving …